Role of chemotherapy after curative esophagectomy in squamous cell carcinoma of the thoracic esophagus: A propensity score‐matched analysis

Role of chemotherapy after curative esophagectomy in squamous cell carcinoma of the thoracic esophagus: A propensity score‐matched analysis

Abstract Background The efficacy of postoperative treatment of squamous cell carcinoma of the esophagus has not yet been determined. In this retrospective study, we investigated whether postoperative adjuvant chemotherapy (POCT) confers a survival benefit on patients who undergo curative esophagecto...

Full description

Bibliographic Details
Main Authors:	Kai Zhu, Peng Ren, Yueyang Yang, Ying Wang, Wanyi Xiao, Hongdian Zhang, Zhentao Yu
Format:	Article
Language:	English
Published:	Wiley 2021-06-01
Series:	Thoracic Cancer
Subjects:	esophageal squamous cell carcinoma postoperative adjuvant chemotherapy metastasis‐positive lymph nodes chemotherapy cycles
Online Access:	https://doi.org/10.1111/1759-7714.13981

Similar Items

Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
by: Bingwen Zou, et al.
Published: (2020-03-01)

Effect of Postoperative Chemotherapy on Prognosis of Postoperative Lymph Node-positive Thoracic Esophageal Squamous Cell Carcinoma Patients
by: SHEN Wenbin, et al.
Published: (2018-10-01)

Long-term survival of patients with locally advanced esophageal squamous cell carcinoma receiving esophagectomy following neoadjuvant chemotherapy: a cohort study
by: Huang Z, et al.
Published: (2019-02-01)

Long-term outcomes and safety of radical transmediastinal esophagectomy with preoperative docetaxel, cisplatin, and 5-fluorouracil combination chemotherapy for locally advanced squamous cell carcinoma of the thoracic esophagus
by: Yukinori Yamagata, et al.
Published: (2020-09-01)

Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
by: Mingqiu Chen, et al.
Published: (2018-08-01)

Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis
by: Qifeng Wang, et al.
Published: (2020-05-01)

S1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection—A Propensity Score Matching Analysis
by: Meng-Che Hsieh, et al.
Published: (2020-08-01)

Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma
by: Zhuge L, et al.
Published: (2020-12-01)

Anatomy of lymphatic drainage of the esophagus and lymph node metastasis of thoracic esophageal cancer
by: Wang Y, et al.
Published: (2018-11-01)

How does presurgical chemotherapy influence the efficiency of treatment for esophageal cancer recurrence after curative esophagectomy?
by: Yusuke Taniyama, et al.
Published: (2019-04-01)

Lymph node metastatic patterns and its clinical significance for thoracic superficial esophageal squamous cell carcinoma
by: An Wang, et al.
Published: (2020-09-01)

Prognostic significance of solitary lymph node metastasis in patients with squamous cell carcinoma of middle thoracic esophagus
by: Wu Jie, et al.
Published: (2012-10-01)

Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients
by: Ao Liu, et al.
Published: (2021-10-01)

Adjuvant chemotherapy versus chemoradiation in high‐risk pancreatic adenocarcinoma: A propensity score‐matched analysis
by: Mustafa Raoof, et al.
Published: (2019-10-01)

The prognostic performance of the log odds of positive lymph nodes in patients with esophageal squamous cell carcinoma: A population study of the US SEER database and a Chinese single‐institution cohort
by: Hongdian Zhang, et al.
Published: (2021-09-01)

Prognostic impact of thoracic duct lymph node metastasis in esophageal squamous cell carcinoma
by: Satoru Matsuda, et al.
Published: (2021-05-01)

Eficácia local e complicações da terapêutica neoadjuvante no carcinoma epidermóide do esôfago: radioterapia versus radioterapia associada à quimioterapia
by: Valdir Tercioti Junior, et al.

Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma
by: Yichun Wang, et al.
Published: (2021-04-01)

Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis
by: Jian Xu, et al.
Published: (2019-06-01)

Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resection
by: Jiazhang Xing, et al.
Published: (2021-09-01)

CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT3-4aN0-1M0) (NCT03001596)
by: Han Tang, et al.
Published: (2017-06-01)

Influence of negative lymph node in No 7 on survival of patients with middle thoracic esophageal squamous cell carcinoma
by: Zhang JL, et al.
Published: (2016-03-01)

Timing of Adjuvant Chemoradiation in pT1-3N1-2 or pT4aN1 Esophageal Squamous Cell Carcinoma After R0 Esophagectomy
by: Wu L, et al.
Published: (2020-10-01)

Multi‐institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer
by: Mitsuro Kanda, et al.
Published: (2019-09-01)

S-1–Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II Trial
by: Xin Wang, et al.
Published: (2020-08-01)

Is Radical Surgery Alone Enough in T1-3N1a Colon Cancer?
by: Guoxiong Xu, et al.
Published: (2020-10-01)

Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?
by: Xu Yaping, et al.
Published: (2012-08-01)

Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma
by: Yuchong Yang, et al.
Published: (2019-05-01)

Risk Factors and Patterns of Abdominal Lymph Node Recurrence After Radical Surgery for Locally Advanced Thoracic Esophageal Squamous Cell Cancer
by: Wang Y, et al.
Published: (2020-05-01)

Chemotherapy alone versus definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: a population-based study
by: Chia-Chin Li, et al.
Published: (2021-04-01)

Pattern of Recurrence in 428 Patients With Thoracic Esophageal Squamous Cell Carcinoma After Radical Surgery and Its Implication in Postoperative Radiotherapeutic Clinical Target Volume
by: Tiantian Cui, et al.
Published: (2021-04-01)

A review of preoperative chemoradiotherapy for lower rectal cancer
by: Naohito Beppu, et al.
Published: (2017-07-01)

Four Cycles of Docetaxel-Cyclophosphamide versus Anthracycline-Taxane as Adjuvant Chemotherapy for HER2-Negative, Axillary Lymph Node Negative Breast Cancer: A Real-World Comparison of Alberta Patients Treated 2008–2012
by: Malek Hannouf, et al.
Published: (2021-03-01)

The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial)
by: Frédérique Penault-Llorca, et al.
Published: (2018-05-01)

Progress of Postoperative Adjuvant Chemotherapy in Stage I Non-small Cell Lung Cancer
by: Bo LIU, et al.
Published: (2015-06-01)

Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node‐positive bladder cancer: A retrospective analysis: KCSG GU 17‐03
by: Woo Kyun Bae, et al.
Published: (2019-09-01)

Role of Log Odds of Positive Lymph Nodes in Predicting Long-term Prognosis of Patients with Thoracic Esophageal Squamous Cell Carcinoma
by: GAO Hongmei, et al.
Published: (2020-03-01)

Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma
by: Seiichi Nakaya, et al.
Published: (2021-07-01)

Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma
by: Peng Chen, et al.
Published: (2020-05-01)

Mapping patterns of metastatic lymph nodes for postoperative radiotherapy in thoracic esophageal squamous cell carcinoma: a recommendation for clinical target volume definition
by: Jing Yu, et al.
Published: (2019-09-01)